Home › Funds › Avidity Partners Management LP › CNTX
Avidity Partners Management LP position in CNTX
CONTEXT THERAPEUTICS INC · Health Care
Avidity Partners Management LP reported holding 4,998,267 shares of CNTX (CONTEXT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$2.8M, representing 0.44% of its reported portfolio and ranking #27 among its reported holdings. Avidity Partners Management LP has disclosed CNTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Avidity Partners Management LP's CNTX position evolved
Avidity Partners Management LP first disclosed a stake in CNTX in Q2 2024 at 7,419,355 shares (US$14.9M). Across 9 filings, Avidity Partners Management LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 4,998,267 shares valued at US$2.8M. Notable position changes include a 39% trim in Q4 2025 (shares rose 78% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 7.42M | $14.88M | New |
| Q3 2024 | 7.42M | $14.54M | Hold |
| Q4 2024 | 7.48M | $7.85M | Add |
| Q1 2025 | 7.48M | $4.58M | Hold |
| Q2 2025 | 7.48M | $4.90M | Hold |
| Q3 2025 | 8.98M | $8.70M | Add |
| Q4 2025 | 5.50M | $8.09M | Reduce |
| Q1 2026 | 5.00M | $13.10M | Reduce |
| Q2 2026 | 5.00M | $2.77M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNTX and 13F data
CNTX (CONTEXT THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in CNTX — the largest reported positions include Nextech Invest Ltd. (US$4.1M), Octagon Capital Advisors LP (US$1.7M), Blue Owl Capital Holdings LP (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNTX
- Nextech Invest Ltd. 7.42M sh · $4.11M · Q2 2026
- Octagon Capital Advisors LP 3.05M sh · $1.69M · Q2 2026
- Blue Owl Capital Holdings LP 2.93M sh · $1.63M · Q2 2026
- MPM BioImpact LLC 1.30M sh · $719.54K · Q2 2026
More on Avidity Partners Management LP
FAQ
How long has Avidity Partners Management LP held CNTX?
Avidity Partners Management LP has disclosed CNTX holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Avidity Partners Management LP's current position in CNTX?
As of Q2 2026, Avidity Partners Management LP holds 5.00M shares of CNTX (CONTEXT THERAPEUTICS INC), valued at $2.77M, representing 0.44% of its reported portfolio and ranking #27.
Has Avidity Partners Management LP been buying or selling CNTX?
In the latest 13F filing (Q2 2026), Avidity Partners Management LP held unchanged its position in CNTX.
Which other funds hold CNTX?
Other major institutional holders of CNTX include Nextech Invest Ltd., Octagon Capital Advisors LP, Blue Owl Capital Holdings LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.